Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Tokyo, April 26, 2011 – Asteallas Pharma Inc. (TOKYO: 4503, “Astellas”) expresses its deepest sympathy for those who have lost their lives and been displaced by the Eastern Japan Earthquake,...
Read more about Astellas Assesses the Impact of the Eastern Japan Earthquake (4th Notice)
Tokyo, April 20, 2011 - Astellas Pharma Inc. (TOKYO:4503,“Astellas”) announced that a new dosage form of Vesicare® (generic name: solifenacin succinate), the orally disintegrating tablet...
Read more about Astellas Launches Orally Disintegrating Tablet "Vesicare® OD" in Japan
Tokyo, April 5, 2011 - Astellas Pharma Inc. (“Astellas”, TSE: 4503) expresses its deepest sympathy for those who have lost their lives and been displaced by the Eastern Japan Earthquake, which...
Read more about Astellas Assesses the Impact of the Eastern Japan Earthquake (3rd Notice)
Tokyo, March 30, 2011 - Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) and Pfizer Japan Inc. (“Pfizer”; Headquarters: Tokyo; President: Ichiro...
Tokyo, March 25, 2011, Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced today that it has established Astellas Pharma d.o.o. in Slovenia....
Read more about Astellas Establishes a new Affiliate In South East Europe
Tokyo, March 23, 2011 - Astellas Pharma Inc. (“Astellas”, TSE: 4503) expresses its deepest sympathy for those who have lost their lives and been displaced by the Tohoku Earthquake, which...
Read more about Astellas Assesses the Impact of the Tohoku Earthquake (2nd Notice)
Follow us
